Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


French diagnostics spending continues to fall:

This article was originally published in Clinica

Executive Summary

French reimbursement for diagnostic tests fell 0.7% in April compared with a slight fall in March of 0.1% over the previous month. Spending on auxiliary procedures, which include EEGs and ECGs, fell 1.2% in April compared with a rise of 0.3% in March. Figures from national medical insurers CNAM show reimbursement for small equipment was Fr 89.5 million ($17.5 million) during the month and Fr 93.3 million for large equipment. April reimbursement for pacemakers was Fr 18.4 million and for other internal prostheses Fr 224.4 million. Total health reimbursement was down 0.4% for the month to Fr 35,505 million.

You may also be interested in...

Sarepta Scores Another Remarkable Approval With Vyondys 53 For Duchenne

Formal dispute resolution was key element in four-month turnaround from rejection by US FDA to approval for golodirsen, the second Sarepta DMD drug to clear the agency after appearing to have minimal prospects.

Real-World Evidence Fails Another Test At US FDA

Correvio’s attempt to move vernakalant from 'clinical hold' to 'FDA approved' was a huge long shot. But the advisory committee vote – and looming FDA rejection – are another indication that real-world data is not a panacea.

Health And Wellness Product Trademark Review 10 December, 2019

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts